Certain Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Recovered from Donors Who Were Tested for Communicable Diseases Using Pooled Specimens or Diagnostic Tests: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 16, 2008
April 23, 2024
2badf630-8585-45e0-8caf-a8078914403e
Related Documents
Compliance with 21 CFR Part 1271150(c)(1) – Manufacturing Arrangements: Guidance for Industry
Guidance DocumentSeptember 8, 2006Center for Biologics Evaluation and Research
Recommendations for Obtaining a Labeling Claim for Communicable Disease Donor Screening Tests Using Cadaveric Blood Specimens from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Guidance for Industry
Guidance DocumentNovember 1, 2004Center for Biologics Evaluation and Research
General Principles for the Development of Vaccines to Protect Against Global Infectious Diseases: Guidance for Industry
Guidance DocumentDecember 1, 2011Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox